Chromoblastomycosis pathology

Author: Assoc Prof Patrick Emanuel, Dermatopathologist, Auckland, New Zealand, 2013.

Chromoblastomycosis (chromomycosis) is caused by quite a variety of pigmented fungal species common in soil and plant matter.

Histology of chromoblastomycosis

Chromoblastomycosis organisms often elicit a profound epidermal hyperplastic reaction which may mimic a squamous cell carcinoma (figures 1, 2). There are often intraepidermal neutrophilic abscesses and transepidermal elimination of inflammatory debris. There is a suppurative and granulomatous response in the dermis (figure 3-6). Eosinophils may be numerous. Later stages often show an impressive dermal fibroplasia.

Within the infiltrate, the organisms can be seen on haematoxylin-eosin sections (figures 3-6, arrows). The organisms are brown, round and have a thick wall. They are thought to represent an intermediate form between hyphae and yeast. The round bodies are sometimes seen fused together as “septate bodies” (figure 4, arrows).

Special studies for chromoblastomycosis

GMS and PAS stains can highlight the fungal forms. The pigment can be appreciated on haematoxylin-eosin sections. Fungal culture can be used to isolate the causative organism.

Differential diagnosis of chromoblastomycosis pathology

Phaeohyphomycosis – Pigmented hyphae are the hallmark of phaeohyphomycosis rather than the round intermediate bodies of chromoblastomycosis.

Sporotrichosis, blastomycosis, coccidiodomycosis, mycobacterial infection – Special stains, culture or PCR can be helpful in difficult cases.

Squamous cell carcinoma, halogenoderma – The massive epidermal hyperplasia which often accompanies chromoblastomycosis my cause diagnostic confusion with these other diverse pathologic processes.

Related information

Make a donation

Donate Today

Help us to update and maintain DermNet New Zealand

The History Of DermNet

Watch Dr Amanda Oakley presenting 'The History Of DermNet NZ' at The International Society Of Teledermatology.

Subscribe to our mailing list

* indicates required
DermNet NZ Newsletter